Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P21817 (
RyR1
)
1,154
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Cysteine-rich secretory proteins (CRISPs) are widely distributed, and notably occur in the mammalian reproductive tract and in the salivary glands of venomous reptiles. Most CRISPs can inhibit ion channels, such as the cyclic nucleotide-gated ion channel, potassium channel, and calcium channel. Natrin is a CRISP that has been purified from snake venom. Its targets include the
calcium-activated potassium channel
, the voltage-gated potassium channel, and the calcium release channel/ryanodine receptor (RyR). Immunoprecipitation experiments showed that natrin binds specifically to type 1 RyR (
RyR1
) from skeletal muscle. Natrin was found to inhibit both the binding of ryanodine to
RyR1
, and the calcium-channel activity of
RyR1
. Cryo-electron microscopy and single-particle image reconstruction analysis revealed that natrin binds to the clamp domains of
RyR1
. Docking of the crystal structure of natrin into our cryo-electron microscopy density map of the
RyR1
+ natrin complex suggests that natrin inhibits
RyR1
by stabilizing a domain-domain interaction, and that the cysteine-rich domain of natrin is crucial for binding. These findings help reveal how natrin toxin inhibits the RyR calcium release channel, and they allow us to posit a generalized mechanism that governs the interaction between CRISPs and ion channels.
...
PMID:Structural and functional characterization of ryanodine receptor-natrin toxin interaction. 1865 24